Peter P. De Deyn
Expertise in
18
conditions

Peter P. De Deyn

Antwerpen, VLG, BE 
Expertise in
18
conditions
Antwerpen, VLG, BE 

Overview

Peter De Deyn practices practicing medicine in Antwerpen, Belgium.

Mr. De Deyn is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Dementia, Alzheimer's Disease, Frontotemporal Dementia, and Vascular Dementia.

He is actively involved in clinical research, co-authoring 362 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Antwerpen, VLG, Belgium
Other Locations
Wilrijk, VLG 2610, Belgium
Born, WAL, Belgium
Edegem, VLG, Belgium
Route De Lennik, No 808, Brussels, BRU 1070, Belgium
Gent, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study, Followed by an Open-Label Extension, to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ISIS 814907 in Patients With Mild Alzheimer's Disease
A Randomized, Double-Blind, Placebo-Controlled Study, Followed by an Open-Label Extension, to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered ISIS 814907 in Patients With Mild Alzheimer's Disease
Enrollment Status: Completed
Publish Date: April 08, 2025
Intervention Type: Drug, Other
Study Drug: IONIS MAPTRx
Study Phase: Phase 1
View 1 Less Clinical Trial

360 Total Publications

Cognitive correlates of cortical thickness, white matter volume, and resting-state connectivity in mild cognitive impairment.
Cognitive correlates of cortical thickness, white matter volume, and resting-state connectivity in mild cognitive impairment.
Journal: Journal of Alzheimer's disease : JAD
Published: January 27, 2026

Frequently Asked Questions about Peter P. De Deyn

Is Peter P. De Deyn a top-rated expert for Dementia?

MediFind is an objective health platform that identifies experts based on real-world data. Peter P. De Deyn is classified as an Elite expert for Dementia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Peter P. De Deyn participate in research or clinical trials?

Yes. Peter P. De Deyn has published 360 articles and abstracts on conditions like Dementia. You can view a list of Peter P. De Deyn's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. De Deyn's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 31 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile